An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA
According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.
Infection prevention and control in the household management of people with suspected or confirmed coronavirus disease (COVID-19)
This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do not require hospitalisation, therefore self-isolating at home.
Infection prevention and control and preparedness for COVID-19 in healthcare settings - second update
This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.
Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union – first update
This document outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-19 response.
Cloth masks and mask sterilisation as options in case of shortage of surgical masks and respirators
This document aims to provide advice on the use of cloth face masks and sterilisation of respirators and surgical masks as an alternative in healthcare settings with suspected or confirmed COVID-19 cases if there is a shortage of specialised surgical masks and respirators.
Disinfection of environments in healthcare and non-healthcare settings potentially contaminated with SARS-CoV-2
This document provides guidance to EU/EEA Member States on environmental cleaning in healthcare and non-healthcare settings during the COVID-19 pandemic.
Considerations related to the safe handling of bodies of deceased persons with suspected or confirmed COVID-19
This document aims to support public health preparedness planning and response activities on the safe handling of bodies of deceased persons with suspected or confirmed COVID-19: at the site of death, during transport, storage and preparation before burial/cremation, and during burial/cremation.
Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA
This document aims to provide a risk assessment and management options for the safe and sustainable supply of substances of human origin (SoHO) to assist the European Union and European Economic Area (EU/EEA) Member States in responding to the threat posed by the coronavirus disease 2019 (COVID-19) pandemic. Following the rapid spread of COVID-19 in the EU/EEA and worldwide, the European Centre for Disease Prevention and Control (ECDC) has published a set of rapid risk assessments and set out measures on how to maintain the safety and sustainability of SoHO supply. It has also been advocating for EU/EEA Member States to activate pandemic plans to prepare for large outbreaks and community transmission of COVID-19.
Considerations relating to social distancing measures in response to COVID-19 – second update
This document aims to support public health preparedness planning and response activities based upon social distancing measures aimed at minimising the spread of COVID-19.
Guidance for health system contingency planning during widespread transmission of SARS-CoV-2 with high impact on healthcare services
This document aims to support public health preparedness planning and response activities when advising healthcare services on approaches on how to increase capacity for managing COVID-19 cases in the context of widespread sustained SARS-CoV-2 transmission in a particular community.